Fabrice Barlesi, Responsable scientifique et technique du RHU PIONeeR at Aix-Marseille Université, Chief Executive Officer at Gustave Roussy, shared Kadans Science Partner’s post on LinkedIn, adding:
“We are inaugurating the HIVE Campus Grand Parc, the first French hub entirely dedicated to innovation in oncology.
Alongside the Paris Saclay Cancer Cluster (PSCC), this place brings together researchers, clinicians, entrepreneurs and industrialists with a common ambition: to accelerate the transition from scientific discovery to innovation for the benefit of patients.
This inauguration marks an important step in the development of the ecosystem of excellence that is being built around Gustave Roussy and the Grand Parc Campus.
Advancing research faster, fostering collaboration and transforming discoveries into concrete solutions: this is the whole point of this collective dynamic.”
Quoting Kadans Science Partner’s post:
“A game changer for oncology innovation in France
The HIVE Campus Grand Parc is officially inaugurated and it’s more than a new building. It’s the launch of France’s first innovation hub fully dedicated to oncology.
The launch took place during the Kadans Oncology Summit, which brought together over 475 researchers, entrepreneurs, representatives and innovators within the oncology ecosystem throughout the day.
Animated by the Paris Saclay Cancer Cluster (PSCC) and next to Gustave Roussy, The HIVE brings together researchers, clinicians, startups and industry leaders with one clear objective: accelerate the journey from scientific discovery to patient impact.
By concentrating the entire innovation chain in a single location, Campus Grand Parc is set to play a key role in tackling one of the biggest challenges in life sciences, bridging the gap between research and real-world application.
A strong signal for the future of health innovation in Europe.
Dive into the full story here.”
Other articles featuring Fabrice Barlesi on OncoDaily.